SILO Pharma Q1 EPS $(0.12) Up From $(0.23) YoY, Sales $18.026K, Same YoY

Benzinga Newsdesk www.benzinga.com Negative 80.2%

Neg 80.2% Neu 0% Pos 0%

SILO Pharma (NASDAQ:SILO) reported quarterly losses of $(0.12) per share. This is a 47.83 percent increase over losses of $(0.23) per share from the same period last year. The company reported $18.026 thousand in sales this quarter. This is the same as the same period last year.